> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Vertex Gets Priority Voucher
- URL: https://www.fdaweb.com/vertex-gets-priority-voucher/
- Published: 2024-01-09T12:00:00.000Z
- Updated: 2026-09-14T14:19:52.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5156104

*Federal Register* notice: FDA is announcing that it issued a priority review voucher (pediatric disease product) to Vertex Pharmaceuticals for gaining approval of Casgevy (exagamglogene autotemcel), indicated for treating sickle cell disease in patients 12 years and older with recurrent vaso-occlusive crises. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-01-09/pdf/2024-00263.pdf?ref=fdaweb.com).